Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

Darlix et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d8d1bff39dfae3cad180d8 — DOI: https://doi.org/10.1038/s41416-019-0619-y

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Clinical Features and Prognostic Factors in Patients with Carcinomatous Meningitis Secondary to Breast Cancer· 2012 · 55 citations
2. Central nervous system metastasis from breast carcinoma autopsy study· 1983 · 1,077 citations
3. Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management· 2017 · 17 citations
4. Brain metastases free survival differs between breast cancer subtypes· 2012 · 93 citations
5. CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)· 2013 · 209 citations